Is JAZZ a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

1,268 people get JAZZ articles and Market Currents by email alert.

Get email alerts on JAZZ »

HEADLINES:

Jazz Pharmaceuticals Public Limited Company Presents at UBS Global Healthcare Conference, May-21-2013 09:30 AM
Tue, May 21
Jazz Pharmaceuticals Public Limited Management Discusses Q1 2013 Results - Earnings Call Transcript
Tue, May 7 • 3 Comments
Cramer's Mad Money - 16 Things To Watch In The Week Ahead (4/26/13)
SA Editor Miriam Metzinger • Sun, Apr 28 • 5 Comments
Does JAZZ Have Any Pizzazz Left?
The Tenacious Trader • Tue, Apr 16 • 7 Comments
Acorda: A Biotech Company To Consider
Northrop Puckett • Sat, Apr 13 • 1 Comment
ISM Leads Market Down Bearish Path
David Brown • Mon, Apr 1
The Weekend Blitz: Finding Value, Market Behavior, & Diversification Related Plays
Brian Nichols • Mon, Mar 18 • 18 Comments
Jazz Pharmaceuticals' CEO Presents at Barclays Global Healthcare Conference (Transcript)
Tue, Mar 12
Intermarket Trends Favor More Upside For Stocks
ONeil Trader • Mon, Mar 11
Jazz Pharmaceuticals: Playing A Sweet Song For Growth Investors
Bret Jensen • Mon, Mar 11 • 7 Comments
Seeking Opportunity: Creating A Plan Of Investment Action
Brian Nichols • Fri, Mar 8 • 22 Comments
Jazz Pharmaceuticals: Music To Our Ears
Capital Traders Group • Sun, Mar 3 • 3 Comments
Jazz Pharmaceuticals Public Limited Management Discusses Q4 2012 Results - Earnings Call Transcript
Tue, Feb 26
VIX - Options Volatility Sonar: Friday Recap
Erick McKitterick • Fri, Jan 11 • 26 Comments
Jazz Pharmaceuticals' CEO Presents at Lazard Capital Markets Healthcare Conference (Transcript)
Wed, Nov 14, 2012
2 Speculative Biotech Plays That Have Potential
Matt Schilling • Fri, Nov 9, 2012 • 2 Comments
Jazz Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcript
Thu, Nov 8, 2012
4 Mid Caps Raking In Profits And Projected For Growth
ZetaKap • Mon, Oct 1, 2012
Biotechnology: Valuation Doesn't Always Indicate Value
Brian Nichols • Mon, Sep 17, 2012 • 28 Comments
7 Rallying Biotech Stocks Being Snapped Up By Hedge Funds
Kapitall • Sat, Sep 15, 2012 • 1 Comment

To learn more about Seeking Alpha Pro, click here.

Does JAZZ Have Any Pizzazz Left?
The Tenacious Trader • Tue, Apr 16 • 7 Comments
Jazz Pharmaceuticals: Playing A Sweet Song For Growth Investors
Bret Jensen • Mon, Mar 11 • 7 Comments
Jazz Pharmaceuticals: Music To Our Ears
Capital Traders Group • Sun, Mar 3 • 3 Comments
Jazz Pharmaceuticals Looking Like An Easy Double On Revenue Explosion
Galileo Russell • Wed, Sep 12, 2012 • 6 Comments
Revenues Are Exploding At This Fast Growing Biopharma Stock
Bret Jensen • Wed, Aug 8, 2012 • 2 Comments
Jazz Pharmaceuticals Can Hit An Interesting Note In 2012
Jessica King Holden • Sun, Feb 26, 2012 • 2 Comments
Jazz Pharmaceuticals Surges On Analyst's Praise Of Takeover Plans
Kapitall • Wed, Sep 21, 2011 • 2 Comments
Will Jazz Pharmaceuticals Turn Sales Into Pipeline Growth?
Todd Campbell • Tue, Sep 13, 2011 • 6 Comments
Jazz Pharmaceuticals: Another Healthcare Sector Flash Crash, Stop-Limits Triggered
Kinetic Investments • Wed, Apr 27, 2011 • 6 Comments
Jazz Pharmaceuticals: When Is FDA Rejection a Good Thing?
Investment U • Mon, Dec 20, 2010 • 1 Comment
Jazz Feels No Pain Following FDA Rejection
EP Vantage • Sun, Oct 17, 2010 • 1 Comment
Jazz: Your FDA Panel Primer
Rockford Coscia • Fri, Jul 30, 2010 • 17 Comments
Jazz Pharmaceuticals Still in Trouble
Eben Tessari • Thu, Jun 12, 2008

Cramer's Mad Money - 16 Things To Watch In The Week Ahead (4/26/13)
SA Editor Miriam Metzinger • Sun, Apr 28 • 5 Comments
Acorda: A Biotech Company To Consider
Northrop Puckett • Sat, Apr 13 • 1 Comment
ISM Leads Market Down Bearish Path
David Brown • Mon, Apr 1
The Weekend Blitz: Finding Value, Market Behavior, & Diversification Related Plays
Brian Nichols • Mon, Mar 18 • 18 Comments
Intermarket Trends Favor More Upside For Stocks
ONeil Trader • Mon, Mar 11
Seeking Opportunity: Creating A Plan Of Investment Action
Brian Nichols • Fri, Mar 8 • 22 Comments
VIX - Options Volatility Sonar: Friday Recap
Erick McKitterick • Fri, Jan 11 • 26 Comments
2 Speculative Biotech Plays That Have Potential
Matt Schilling • Fri, Nov 9, 2012 • 2 Comments
4 Mid Caps Raking In Profits And Projected For Growth
ZetaKap • Mon, Oct 1, 2012
Biotechnology: Valuation Doesn't Always Indicate Value
Brian Nichols • Mon, Sep 17, 2012 • 28 Comments
7 Rallying Biotech Stocks Being Snapped Up By Hedge Funds
Kapitall • Sat, Sep 15, 2012 • 1 Comment
3 Vaccine Companies With Upcoming Catalysts - Part II
Markus Aarnio • Wed, Sep 12, 2012 • 2 Comments
Top 3 Stock Upgrades On September 11
Jorge Aura • Wed, Sep 12, 2012 • 3 Comments
Top 5 Insider Sells Filed On August 31
Markus Aarnio • Sat, Sep 1, 2012 • 6 Comments
BioPharma Stock Movers For Wednesday, August 29
Scott Matusow • Wed, Aug 29, 2012 • 15 Comments
7 Fast Growing Mid Cap Stocks Raking In Profits
ZetaKap • Wed, Aug 29, 2012 • 1 Comment
Discovery Laboratories: Reiterating Buy, The Street Is Getting On Board
Smith On Stocks • Mon, Aug 27, 2012 • 7 Comments
3 Growth Mid Cap Stocks To Consider
Supreme Alpha • Wed, Aug 22, 2012
Many Women Know The Obagi Name, So Should Investors
Scott Matusow • Tue, Aug 21, 2012 • 4 Comments
ImmunoCellular CEO Steps Down But Leaves Company Well Positioned
Brian Nichols • Mon, Aug 20, 2012 • 56 Comments

Jazz Pharmaceuticals Public Limited Company Presents at UBS Global Healthcare Conference, May-21-2013 09:30 AM
Tue, May 21
Jazz Pharmaceuticals Public Limited Management Discusses Q1 2013 Results - Earnings Call Transcript
Tue, May 7 • 3 Comments
Jazz Pharmaceuticals' CEO Presents at Barclays Global Healthcare Conference (Transcript)
Tue, Mar 12
Jazz Pharmaceuticals Public Limited Management Discusses Q4 2012 Results - Earnings Call Transcript
Tue, Feb 26
Jazz Pharmaceuticals' CEO Presents at Lazard Capital Markets Healthcare Conference (Transcript)
Wed, Nov 14, 2012
Jazz Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcript
Thu, Nov 8, 2012
Jazz Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript
Wed, Aug 8, 2012 • 1 Comment
Jazz Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript
Wed, May 5, 2010
Jazz Pharmaceuticals Inc. Q2 2008 Earnings Call Transcript
Fri, Aug 8, 2008
Jazz Pharmaceuticals, Inc. Q1 2008 Earnings Call Transcript
Tue, May 13, 2008

Cramer's Homework Uncovers Stock Concerns

at CNBC.com (Apr 26, 2013)
Lightning Round: Cypress Semi, Stewart, Jazz Pharma and More

at CNBC.com (Mar 19, 2013)
The Technical Indicator: Charting the S&P’s test of record territory

at MarketWatch.com (Mar 12, 2013)
Early Movers: JCP, DELL, NFLX & More

at CNBC.com (Mar 5, 2013)
The Technical Indicator: Charting the fourth-quarter start

at MarketWatch.com (Oct 2, 2012)
Lightning Round: DirecTV, Exxon, Jazz and More

at CNBC.com (Aug 15, 2012)
Stocks to Watch: DELL, FB, GES & More

at CNBC.com (May 22, 2012)
The Technical Indicator: Nasdaq sustains break to 11-year highs

at MarketWatch.com (Feb 7, 2012)
The Technical Indicator: January uptrend meets major resistance

at MarketWatch.com (Jan 24, 2012)
Movers & Shakers: Friday’s biggest gaining and declining stocks

at MarketWatch.com (Jan 6, 2012)
Stocks to Watch: Stocks to watch Friday: Alcoa, RF Micro Devices

at MarketWatch.com (Jan 6, 2012)
Jazz Pharmaceuticals Provides Financial Outlook for 2012

PR Newswire (Jan 5, 2012)
Jazz Pharmaceuticals to Hold Investor Conference Call on January 5 to Discuss 2012 Financial Guidance and Azur Pharma Transaction

PR Newswire (Jan 4, 2012)
Jazz Pharmaceuticals Announces Stockholder Vote in Favor of Transaction With Azur Pharma Limted

PR Newswire (Dec 12, 2011)
Always Nice to Get a Lucky Bounce

at CNBC.com (Sep 21, 2011)
Dow Ekes Out Small Gain; S&P, Nasdaq Lower

at CNBC.com (Sep 20, 2011)
Stocks to Watch: Stocks to watch Tuesday: ConAgra, Air Products

at MarketWatch.com (Sep 20, 2011)
After Hours: Stock futures fall after hours as Italy downgraded

at MarketWatch.com (Sep 19, 2011)
Marder on Markets: The vaudeville market

at MarketWatch.com (Sep 8, 2011)
Marder on Markets: Euro jitters sink shares

at MarketWatch.com (Sep 7, 2011)

JAZZ vs. ETF Alternatives

Company Description

We are a specialty pharmaceutical company that, since our inception, has focused on the development and commercialization of pharmaceutical products to meet important unmet medical needs in neurology and psychiatry. With our JZP-6 product candidate for the treatment of fibromyalgia, for which we... More

Sector: Healthcare

Industry: Biotechnology

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Wednesday, May 8, 12:26 PM Jazz Pharmaceuticals (JAZZ -10%) gets slammed in spite of a solid Q1 earnings beat late yesterday, as investors focus on potential changes at the FDA which could lead the way to approving a generic version of JAZZ's narcolepsy medicine Xyrem, which is currently being produced by Roxane. Xyrem generated $117.5M in sales this quarter alone, nearly 60% of its revenue. Comment! [Healthcare, Earnings, On the Move]
Tuesday, May 7, 4:15 PM Jazz Pharma (JAZZ): Q1 EPS of $1.37 beats by $0.02. Revenue of $196.2M beats by $. Shares +5.1% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
Tuesday, May 7, 12:10 AM Notable earnings after Tuesday’s close: ANDE, ARAY, AWK, AXLL, BIO, BIOL, BMC, BWC, CA, CDXS, CHRW, CODI, DGI, DGIT, DIS, DVA, EA, ENPH, EXEL, GA, GPOR, HTA, IAG, JAZZ, KGC, LYV, MAKO, MCEP, MCK, MDLZ, MITK, MRO, MYGN, NVTL, OAS, OCLR, OHI, ONXX, ORA, PRI, RBCN, SD, SGEN, SYMC, SYNC, TRIP, TWO, URS, VCLK, WBMD, WFM, WMB, WPZ, WTI, Z 1 Comment [Earnings]
Monday, May 6, 5:35 PM Notable earnings after Tuesday’s close: ANDE, ARAY, AWK, AXLL, BIO, BIOL, BMC, BWC, CA, CDXS, CHRW, CODI, DGI, DGIT, DIS, DVA, EA, ENPH, EXEL, GTEK, GA, GPOR, IAG, JAZZ, KGC, LYV, MAKO, MCEP, MCK, MDLZ, MITK, MRO, MYGN, NVTL, OAS, OCLR, OHI, ONXX, ORA, PRI, RBCN, SD, SGEN, SYMC, SYNC, TRIP, TWO, URS, VCLK, WBMD, WFM, WMB, WPZ, WTI, Z 1 Comment [Earnings]
Thursday, March 14, 1:36 PM Jazz Pharmaceuticals (JAZZ -0.4%) says regulators have given final approval to a generic version of the company's Luvox CR anti-depressant by Par Pharmaceutical. Additionally, Kohlberg Kravis Roberts (KKR) confirnms that it sold around 3.73M shares late last week at $58.28 each for $218.5M in gross proceeds, reducing its stake to around 6.5%. 1 Comment [Healthcare]
Monday, March 11, 11:59 AM Jazz Pharmaceuticals (JAZZ +0.9%) moves higher today after Cantor Fitzgerald starts coverage with a Buy rating and $86.00 price target. Cantor calls JAZZ an attractive growth story that's been held back by generic concerns over its key revenue driver, Xyrem, a drug for the treatment of narcolepsy, which represents 69% of revenue. Comment! [Healthcare, On the Move]
Monday, March 4, 7:00 PM Jazz Pharmaceuticals (JAZZ) announces plans for underwritten public offering of 5.375M shares of its stock held by certain shareholders. JAZZ will not receive any proceeds from the offering. Barclays is acting as sole book-running manager for the offering. Shares -2.1% AH. Comment! [Healthcare, On the Move]
Tuesday, February 26, 4:35 PM More on Jazz Pharma (JAZZ): Q4 EPS easily beats estimates. Net sales of Xyrem were $113.5M, compared to net sales of $71.8M for Q411. Gross margin was 85.8% compared to 95.2% for 2011. For FY13, the company expects an EPS of $5.70-5.90 on sales of $805M - 835M, above Street estimates of $5.67 on revenue of $811.3M. Shares +2% AH. Comment! [Healthcare, Earnings, On the Move]
Tuesday, February 26, 4:07 PM Jazz Pharmaceuticals (JAZZ): Q4 EPS of $1.53 beats by $0.12. Revenue of $183.7M misses by $0.1M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Tuesday, February 26, 12:10 AM Notable earnings after Tuesday’s close: AVGO, AWK, DGI, DWA, EIX, FSLR, GA, GPOR, GWRE, HRZN, JAZZ, MAKO, MIDD, NUVA, ORA, PCLN, QCOR, RENN, REXX, RRC, SPN, STEC, TIVO, VNO, VRSK, ZAGG Comment! [Earnings]
Monday, February 25, 5:35 PM Notable earnings after Tuesday’s close: AVGO, AWK, DGI, DWA, EIX, FSLR, GA, GPOR, GWRE, HRZN, JAZZ, MAKO, MIDD, NUVA, ORA, PCLN, QCOR, RENN, REXX, RRC, SPN, STEC, TIVO, VNO, VRSK, ZAGG Comment! [Earnings]
Thursday, January 24, 4:48 AM The FDA won't appeal a decision to overturn the conviction of a salesmen who was found guilty of marketing narcolepsy drug Xyrem for treating drowsiness and chronic fatigue, two conditions for which the medicine wasn't approved. A court quashed the conviction because it said FDA regulations violated free speech in a decision that could have wide ramifications for the agency's ability to regulate off-label drug marketing. 3 Comments [Healthcare]
Thursday, December 13, 2012, 6:21 PM Jazz Pharmaceuticals (JAZZ) says the FDA has denied its 'Citizen Petition' filed in July, addressing requirements for the submission of any Abbreviated New Drug Application of any referencing Xyrem, including the ANDA submitted by Roxane Laboratories. JAZZ claimed the ANDA woulndn't have sufficient risk controls, but the agency said the ANDA would not have demonstrated the new generic drug product would have the same labeling and conditions of use as Xyrem. Comment! [Healthcare]
Monday, December 10, 2012, 7:35 PM Jazz Pharmaceuticals (JAZZ) presented data today from the largest safety trial to date of patients treated with Erwinaze for acute lymphoblastic leukemia who developed a hypersensitivity to E.coli-derived asparaginase. The trial, which was presented at the American Society of Hematology Annual Meeting and Exposition, includes additional follow up data that further describe the incidence of adverse events associated with Erwinaze treatment, which are consistent with the drug's known safety profile. Comment! [Healthcare]
Thursday, November 8, 2012, 4:22 PM Jazz Pharmaceutical (JAZZ): $1.29 misses by $0.03. Revenue of $175M misses by $4M. Shares -1% AH. (PR) 1 Comment [Healthcare, Earnings, On the Move]
Thursday, November 8, 2012, 12:10 AM Notable earnings after Thursday’s close: AFFY, AGO, CBOU, CUBE, DAR, DGIT, DIS, DLB, DNN, EGLE, EVEP, GRPN, HALO, HOGS, IGT, IO, JAZZ, JWN, LGF, MCHP, MDRX, MKL, NVDA, PSA, RNDY, SD, SPRD, SQNM, UBNT, WPRT, WR, ZGNX, ZIP Comment! [Earnings]

Capitalist Bull
Not much left to do, few setups remain. Patiently hold leading growth stocks through 1st pullbacks. http://stks.co/bV7p $ES_F $JAZZ $OCN
Tue, 1:44 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

whitehead1
good opportunity to buy $JAZZ today for short term trade
May 8, 10:14 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ONeil Trader
$JAZZ tight weekly closes. Preparing to go higher http://stks.co/aNuW
Mar 18, 6:33 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ltfinger
Today's New Upgrades (3/12/13): $ACE, $JAZZ, $LPNT, $MCRS, $SNDK, $STX
Mar 12, 11:15 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
ABAXIS ($ABAX), Jazz Pharmaceuticals ($JAZZ), Oaktree Capital ($OAK), Apogee Enterprises ($APOG), & Stepan ($SCL) rose Monday on unusual vol
Mar 12, 4:04 AM
Reply (1)

• !Report Abuse
View all 1 replies
Michael Bryant: However, the only one I'll buy is Jazz Pharmaceuticals ($JAZZ).
Mar 12, 4:05 AM
• !Report Abuse
Add a reply...

140 characters

ltfinger
ARM 3T Trend Analysis MTT BUY (3/11/13): $CAJ, $JAZZ, $SQM, $URBN, $VPHM
Mar 11, 11:11 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ltfinger
ARM 3T Trend STT BUY (3/11/13): $ANV, $BBL, $BEAM, $CAJ, $CNH, $DSW, $EC, $GTLS, $JAZZ, $MDCO, $MHFI, $MRC, $QCOR, $RGLD, $SQM, $URBN
Mar 11, 11:06 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ONeil Trader
Intermarket Trends Favor More Upside For Stocks http://goo.gl/zpjhb $SPY $TLT $XLU $XLP $JAZZ $V $MA $SODA $PJC
Mar 11, 1:55 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Stratasys ($SSYS), Jazz Pharma ($JAZZ), Valmont Industries ($VMI), Saia ($SAIA), & DXP Enterprises ($DXPE) rose Monday on unusual volume.
Mar 4, 11:34 PM
Reply (3)

• !Report Abuse
View all 3 replies
Michael Bryant: Thanks for noting. Guess $DXPE is a longterm winner.
Mar 5, 7:56 AM
• !Report Abuse
1980XLS-2.0: $DXPE 90 day return 45% http://seekingalpha.com/s/1ivu7
Mar 5, 9:03 AM
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
Kansas City Southern ($KSU), Jazz Pharma ($JAZZ), J.B. Hunt ($JBHT), HomeAway ($AWAY), & athenahealth ($ATHN) rose Wednesday on unusual vol.
Feb 28, 4:38 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Michael Bryant
ABAXIS ($ABAX), Jazz Pharmaceuticals ($JAZZ), Oaktree Capital ($OAK), Apogee Enterprises ($APOG), & Stepan ($SCL) rose Monday on unusual vol
Mar 12, 4:04 AM
Reply (1)

• !Report Abuse
View all 1 replies
Michael Bryant: However, the only one I'll buy is Jazz Pharmaceuticals ($JAZZ).
Mar 12, 4:05 AM
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
Stratasys ($SSYS), Jazz Pharma ($JAZZ), Valmont Industries ($VMI), Saia ($SAIA), & DXP Enterprises ($DXPE) rose Monday on unusual volume.
Mar 4, 11:34 PM
Reply (3)

• !Report Abuse
View all 3 replies
Michael Bryant: Thanks for noting. Guess $DXPE is a longterm winner.
Mar 5, 7:56 AM
• !Report Abuse
1980XLS-2.0: $DXPE 90 day return 45% http://seekingalpha.com/s/1ivu7
Mar 5, 9:03 AM
• !Report Abuse
Add a reply...

140 characters

smokeyRose
What is up with $JAZZ ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
12/10/12
Reply (2)

• !Report Abuse
View all 2 replies
realornot: Let's dance, shall we?
12/10/12
• !Report Abuse
smokeyRose: Yes.....But the Music needs to Be A little sweeter!!!! http://bit.ly/VvoQm3
12/10/12
• !Report Abuse
Add a reply...

140 characters

smokeyRose
Should i sell Should i sell My $JAZZ and $NPSP and Buy $SRPT ????? What to do What To Do What To Do
11/26/12
Reply (2)

• !Report Abuse
View all 2 replies
realornot: http://bit.ly/WSDmd5
11/26/12
• !Report Abuse
smokeyRose: he he he
11/26/12
• !Report Abuse
Add a reply...

140 characters

Noreika
<-- Jealous of whoever bought and held JAZZ since '09. Wow, amazing!
4/27/12
Reply (2)

• !Report Abuse
View all 2 replies
tippycanoes: I bought under a dollar...sold at 6$... it haunts me. Literally could have retired
4/27/12
• !Report Abuse
Noreika: I bet!! It's crazy just to look at that chart.
4/27/12
• !Report Abuse
Add a reply...

140 characters

Brandon Gibbs
Long, CLMT TQNT JAZZ KO EVN. CLMT shares w/ XLE options to hedge has worked excellent. By the way, boring super bowl overall.. or just me?
2/7/12
Reply (14)

• !Report Abuse
View all 14 replies
stocktrend: For a nice bounce to 6.80 level? Good luck to you friend.
3/2/12
• !Report Abuse
Brandon Gibbs: Good luck to you too
3/2/12
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
Jazz Pharmaceuticals (JAZZ) keeps rising. Could be good longterm holding. http://yhoo.it/yGLaZa;c=
2/6/12
Reply (2)

• !Report Abuse
View all 2 replies
Brandon Gibbs: Long JAZZ
2/7/12
• !Report Abuse
Brandon Gibbs: Little pull back to $45 would be nice.
2/7/12
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
Crown Castle (CCI), J.B. Hunt (JBHT), Jazz Pharma (JAZZ), Body Central (BODY), & Trimble Navigation (TRMB) rose Friday on unusual volume.
1/29/12
Reply (5)

• !Report Abuse
View all 5 replies
Michael Bryant: Lawsuit.
1/29/12
• !Report Abuse
SlingWing9: They've all got lawsuits against them. All of them have legal depts, all allocate billions/yr for legal issues. Find one TBTF w/o lawsuits
1/29/12
• !Report Abuse
Add a reply...

140 characters

anonymous#12
JAZZ halted pending news. I remember when that stock was at $0.60....now over $40
1/18/12
Reply (1)

• !Report Abuse
View all 1 replies
losbronces: And that is why people still play biotechs even though the odds of success are low.
1/18/12
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
CVR Partners (UAN), Polaris (PII), Jazz Pharmaceuticals (JAZZ), Weight Watchers (WTW), & Greenbrier (GBX) rose Friday on unusual volume.
1/8/12
Reply (3)

• !Report Abuse
View all 3 replies
Michael Bryant: They also give possible buying names. UAN has shown up the most so far.
1/9/12
• !Report Abuse
SlingWing9: Someone also unloaded a lot of MLPL. Dividend is still at 9.3%.
1/9/12
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
Not bad. Jazz Pharma (JAZZ) up 2%. Ulta Salon (ULTA) up 3.27%. Cabot Oil & Gas (COG) up 0.13%. http://seekingalpha.com/a/6rmy
12/23/11
Reply (3)

• !Report Abuse
View all 3 replies
Michael Bryant: Samson (SSN) up 5.88%. Both are Bakken shale plays.
12/23/11
• !Report Abuse
tashe: SSN also had abt 2X vol
12/24/11
• !Report Abuse
Add a reply...

140 characters

Joshua Hayes
new instablog: Rally Attempt Begins with Two Days of Gains. Medical stocks are our leaders. VRUS ELN JAZZ STAA ALXN BIIB RGEN MAKO OSUR BMY
10/5/11
Reply (1)

• !Report Abuse
View all 1 replies
cowpieTX: i manage a diagnostic imaging center for a 17b market cap company. the cuts are real and they are deep. tread carefully.
10/5/11
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
Jazz Pharmaceuticals (JAZZ) is rising on unusual volume. It is a definite buy. PE ratio is very low.
9/20/11
Reply (2)

• !Report Abuse
View all 2 replies
1980XLS: JAZZ http://yhoo.it/nmRnfz
9/20/11
• !Report Abuse
Michael Bryant: That makes it an even better buy.
9/20/11
• !Report Abuse
Add a reply...

140 characters

JAZZ Jazz Pharmaceuticals, Inc.

JAZZ

Jazz Pharmaceuticals, Inc.